Long noncoding RNA cancer susceptibility candidate 9 promotes doxorubicin‑resistant breast cancer by binding to enhancer of zeste homolog 2

The present study aimed to investigate the effect of the long noncoding RNA cancer susceptibility candidate 9 (CASC9) on doxorubicin (DOX)‑resistant breast cancer and to reveal the potential underlying mechanisms. The expression of CASC9 in breast cancer tissues and cell lines, in addition to drug‑r...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of molecular medicine 2018-11, Vol.42 (5), p.2801-2810
Hauptverfasser:	Jiang, Baohong, Li, Yuehua, Qu, Xiaofei, Zhu, Hongbo, Tan, Yeru, Fan, Qun, Jiang, Yiling, Liao, Mingchu, Wu, Xiaoping
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Apoptosis - drug effects Blotting, Western Breast cancer Breast Neoplasms - drug therapy Cancer therapies Cell growth Cell Movement - drug effects Cell Survival - drug effects Chemotherapy Committees Doxorubicin - pharmacology Doxorubicin - therapeutic use Drug resistance Enhancer of Zeste Homolog 2 Protein - genetics Enhancer of Zeste Homolog 2 Protein - metabolism Female Gastric cancer Humans MCF-7 Cells Metastasis Middle Aged Multidrug resistant organisms Proteins RNA, Long Noncoding - genetics RNA, Long Noncoding - metabolism Studies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!